Hematologic side effects of biologics and kinase inhibitors used in rheumatologic diseases: a review of the current evidence
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00277-022-04896-7.pdf
Reference59 articles.
1. Furst DE (2017) Overview of biologic agents and kinase inhibitors in the rheumatic diseases - UpToDate. UpToDate. Published online
2. Tanaka Y (2021) Recent progress in treatments of rheumatoid arthritis: an overview of developments in biologics and small molecules, and remaining unmet needs. Rheumatology 60(Supplement_6):vi12–vi20. https://doi.org/10.1093/rheumatology/keab609
3. Bessissow T, Renard M, Hoffman I, Vermeire S, Rutgeerts P, Van Assche G (2012) Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy. Aliment Pharmacol Ther 36(4):312–323. https://doi.org/10.1111/j.1365-2036.2012.05189.x
4. Feuerstein JD, Cheifetz AS (2014) Miscellaneous adverse events with biologic agents (excludes infection and malignancy). Gastroenterol Clin N Am 43(3):543–563. https://doi.org/10.1016/j.gtc.2014.05.002
5. Sebastian S, Ashton K, Houston Y, Diggory TM, Dore P (2012) Anti-TNF therapy induced immune neutropenia in Crohns disease- report of 2 cases and review of literature. J Crohns Colitis 6(6):713–716. https://doi.org/10.1016/j.crohns.2012.01.014
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. TNF-Alpha Inhibitors Induced Eosinophilia: An Undervalued Side Effect of Such Biologicals;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-07-22
2. Rational approach to the prescription of anti-rheumatic drugs in rheumatoid arthritis: a product leaflet-based strategy in Italy;Frontiers in Immunology;2024-06-24
3. Association of Tumor Necrosis Factor Inhibitors with the Risk of Nontuberculous Mycobacterial Infection in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study;Journal of Clinical Medicine;2023-11-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3